Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access| peer-reviewed journal| indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment| cellular and molecular characterization| prevention| detection| diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original| peer-reviewed| science-based research that successfully advances clinical medicine toward the goal of improving patients' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles| Editorials and Brief Articles.
数据整理自公开网络的投稿反馈，仅供参考。
